Treatment of Vascular Rejection With Rituximab in Cardiac Transplantation

This publication has 13 references indexed in Scilit:

• Rituximab as Treatment for Refractory Kidney Transplant Rejection
  American Journal of Transplantation, 2004
• Humanized anti‐CD20 monoclonal antibody (Rituximab) treatment for post‐transplant lymphoproliferative disorder*
  Clinical Transplantation, 2003
• Fulminant mixed humoral and cellular rejection in a cardiac transplant recipient: a review of the histologic findings and literature
  The Journal of Heart and Lung Transplantation, 2003
• Successful treatment with rituximab of lymphoproliferative disorder in a child after cardiac transplantation
  The Journal of Heart and Lung Transplantation, 2002
• Treatment of humoral rejection with rituximab
  The Annals of Thoracic Surgery, 2002
• Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report
  Transplantation, 2002
• Treatment of post-transplant lymphoproliferative disorder with monoclonal cd20 antibody (rituximab) after heart transplantation
  The Journal of Heart and Lung Transplantation, 2001
• Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab
  Bone Marrow Transplantation, 2001
• Case 2: cardiogenic shock due to acute vascular rejection in a heart transplant recipient.
  The Journal of Heart and Lung Transplantation, 2000
• Risk factors for side effects during first infusion of rituximab—definition of a low risk group
  Medical Oncology, 2000